Genetic modifications of mouse proopiomelanocortin peptide processing

Molecular and Cellular Endocrinology

Volumn 336, Issue 1-2, 2011, Pages 14-22

  Costa, Jessica L ^a   Forbes, Stacy ^b   Brennan, Miles B ^c   Hochgeschwender, Ute ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b DUKE UNIVERSITY   (United States)

^c Greffex Inc   (United States)

Author keywords

MSH; ACTH; Adrenal; Mouse model; Mutant; Obesity

Indexed keywords

ALDOSTERONE; ALPHA INTERMEDIN; CORTICOSTERONE; PROOPIOMELANOCORTIN;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; GENE MUTATION; HORMONE SYNTHESIS; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; WILD TYPE;

ADRENAL GLANDS; ALPHA-MSH; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CHROMOSOMES, ARTIFICIAL, BACTERIAL; DNA, RECOMBINANT; GENOTYPE; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTATION; PHENOTYPE; PRO-OPIOMELANOCORTIN; PROTEIN PROCESSING, POST-TRANSLATIONAL; REPRODUCIBILITY OF RESULTS;

EID: 79952068881     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.12.032     Document Type: Article

References (40)

1. Al-Dujaili E.A., Hope J., Estivariz F.E., Lowry P.J., Edwards C.R. Circulating human pituitary pro-gamma-melanotropin enhances the adrenal response to ACTH. Nature 1981, 291:156-159.
2. Al-Dujaili E.A., Williams B.C., Edwards C.R., Salacinski P., Lowry P.J. Human gamma-melanotropin precursor potentiates corticotropin-induced adrenal steroidogenesis by stimulating mRNA synthesis. Biochem. J. 1982, 204:301-305.
3. Baird A., Kan K.W., Solomon S. Role of pro-opiomelanocortin-derived peptides in the regulation of steroid production by human fetal adrenal cells in culture. J. Endocrinol. 1983, 97:357-367.
4. Bateman A., Dell A., Whitehouse B.J., Vinson G.P. Non-ACTH components of adult human pituitary extracts which stimulate adrenal steroidogenesis. Neuropeptides 1986, 7:381-390.
5. Bertagna X. Proopiomelanocortin-derived peptides. Endocrinol. Metab. Clin. North Am. 1994, 23:467-485.
6. Bicknell A.B., Lomthaisong K., Woods R.J., Hutchinson E.G., Bennett H.P., Gladwell R.T., Lowry P.J. Characterization of a serine protease that cleaves pro-gamma-melanotropin at the adrenal to stimulate growth. Cell 2001, 105:903-912.
7. Bicknell A.B. Identification of a receptor for N-POMC peptides. Endocr. Res. 2002, 28:309-314.
8. Biebermann H., Castaneda T.R., van Landeghem F., von Deimling A., Escher F., Brabant G., Hebebrand J., Hinney A., Tschop M.H., Gruters A., Krude H. A role for beta-melanocyte-stimulating hormone in human body-weight regulation. Cell Metab. 2006, 3:141-146.
9. Challis B.G., Coll A.P., Yeo G.S., Pinnock S.B., Dickson S.L., Thresher R.R., Dixon J., Zahn D., Rochford J.J., White A., Oliver R.L., Millington G., Aparicio S.A., Colledge W.H., Russ A.P., Carlton M.B., O'Rahilly S. Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36). Proc. Natl. Acad. Sci. U.S.A. 2004, 101:4695-4700.
10. Coll A.P., Challis B.G., Yeo G.S., Snell K., Piper S.J., Halsall D., Thresher R.R., O'Rahilly S. The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin. Endocrinology 2004, 145:4721-4727.
11. Costa J.L., Bui S., Reed P., Dores R.M., Brennan M.B., Hochgeschwender U. Mutational analysis of evolutionarily conserved ACTH residues. Gen. Comp. Endocrinol. 2004, 136:12-16.
12. Estivariz F.E., Iturriza F., McLean C., Hope J., Lowry P.J. Stimulation of adrenal mitogenesis by N-terminal proopiocortin peptides. Nature 1982, 297:419-422.
13. Estivariz F.E., Morano M.I., Carino M., Jackson S., Lowry P.J. Adrenal regeneration in the rat is mediated by mitogenic N-terminal pro-opiomelanocortin peptides generated by changes in precursor processing in the anterior pituitary. J. Endocrinol. 1988, 116:207-216.
14. Fassnacht M., Hahner S., Hansen I.A., Kreutzberger T., Zink M., Adermann K., Jakob F., Troppmair J., Allolio B. N-terminal proopiomelanocortin acts as a mitogen in adrenocortical tumor cells and decreases adrenal steroidogenesis. J. Clin. Endocrinol. Metab. 2003, 88:2171-2179.
15. Giraldo P., Montoliu L. Size matters: use of YACs, BACs and PACs in transgenic animals. Transgenic Res. 2001, 10:83-103.
16. Heintz N. BAC to the future: the use of bac transgenic mice for neuroscience research. Nat. Rev. Neurosci. 2001, 2:861-870.
17. Hochgeschwender U., Weltzien H.U., Eichmann K., Wallace R.B., Epplen J.T. Preferential expression of a defined T-cell receptor beta-chain gene in hapten-specific cytotoxic T-cell clones. Nature 1986, 322:376-378.
18. Karpac J., Ostwald D., Bui S., Hunnewell P., Shankar M., Hochgeschwender U. Development, maintenance, and function of the adrenal gland in early postnatal pro-opiomelanocortin null mutant mice. Endocrinology 2005, 146:2555-2562.
19. Koenig W. Peptide and Protein Hormones 1993, VCH, New York.
20. Krude H., Biebermann H., Luck W., Horn R., Brabant G., Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 1998, 19:155-157.
21. Kuo T.H., Tchen T.T. Comparison of the effects of adrenocorticotropic hormone on the steroidogenic activity and ultrastructure of adrenal cortex. J. Biol. Chem. 1973, 248:6679-6683.
22. Laws S.C., Hotchkiss M., Ferrell J., Jayaraman S., Mills L., Modic W., Tinfo N., Fraites M., Stoker T., Cooper R. Chlorotriazine herbicides and metabolites activate an ACTH-dependent release of corticosterone in male Wistar rats. Toxicol. Sci. 2009, 112:78-87.
23. Lee Y.S., Challis B.G., Thompson D.A., Yeo G.S., Keogh J.M., Madonna M.E., Wraight V., Sims M., Vatin V., Meyre D., Shield J., Burren C., Ibrahim Z., Cheetham T., Swift P., Blackwood A., Hung C.C., Wareham N.J., Froguel P., Millhauser G.L., O'Rahilly S., Farooqi I.S. A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab. 2006, 3:135-140.
24. Lowry P.J., Silas L., McLean C., Linton E.A., Estivariz F.E. Pro-gamma-melanocyte-stimulating hormone cleavage in adrenal gland undergoing compensatory growth. Nature 1983, 306:70-73.
25. Muyrers J.P., Zhang Y., Testa G., Stewart A.F. Rapid modification of bacterial artificial chromosomes by ET-recombination. Nucleic Acids Res. 1999, 27:1555-1557.
26. Muyrers J.P., Zhang Y., Benes V., Testa G., Ansorge W., Stewart A.F. Point mutation of bacterial artificial chromosomes by ET recombination. EMBO Rep. 2000, 1:239-243.
27. Muyrers J.P., Zhang Y., Stewart A.F. Techniques: recombinogenic engineering-new options for cloning and manipulating DNA. Trends Biochem. Sci. 2001, 26:325-331.
28. Nagy A., Gertsenstein M., Vintersten K., Behringer R. Manipulating the Mouse Embryo. A Laboratory Manual 2003, Cold Spring Harbor Laboratory Press Cold Spring Harbor.
29. Pedersen R.C., Brownie A.C. Adrenocortical response to corticotropin is potentiated by part of the amino-terminal region of pro-corticotropin/endorphin. Proc. Natl. Acad. Sci. U.S.A. 1980, 77:2239-2243.
30. Pedersen R.C., Brownie A.C., Ling N. Pro-adrenocorticotropin/endorphin-derived peptides: coordinate action on adrenal steroidogenesis. Science 1980, 208:1044-1046.
31. Prickaerts J., Moechars D., Cryns K., Lenaerts I., van Craenendonck H., Goris I., Daneels G., Bouwknecht J.A., Steckler T. Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J. Neurosci. 2006, 26:9022-9029.
32. Shima S., Matsuba M., Pincus G. Effects of hypophysectomy on rat adrenal corticosteroidogenesis in vivo. Endocrinology 1968, 82:21-28.
33. Smith G.W., Aubry J.M., Dellu F., Contarino A., Bilezikjian L.M., Gold L.H., Chen R., Marchuk Y., Hauser C., Bentley C.A., Sawchenko P.E., Koob G.F., Vale W., Lee K.F. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 1998, 20:1093-1102.
34. Stallings N.R., Hanley N.A., Majdic G., Zhao L., Bakke M., Parker K.L. Development of a transgenic green fluorescent protein lineage marker for steroidogenic factor 1. Mol. Endocrinol. 2002, 16:2360-2370.
35. Szalay K.S. Effects of pro-opiomelanocortin peptides on adrenocortical steroidogenesis. J. Steroid Biochem. Mol. Biol. 1993, 45:141-146.
36. Vernikos-Danellis J. Sensitivity of the adrenal corticosterone response to ACTH as a function of time after hypophysectomy. Endocrinology 1969, 84:1507-1508.
37. Vinson G.P., Whitehouse B.J., Dell A., Etienne T., Morris H.R. Characterisation of an adrenal zona glomerulosa-stimulating component of posterior pituitary extracts as alpha-MSH. Nature 1980, 284:464-467.
38. Yaswen L., Diehl N., Brennan M.B., Hochgeschwender U. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat. Med. 1999, 5:1066-1070.
39. Zhang Y., Buchholz F., Muyrers J.P., Stewart A.F. A new logic for DNA engineering using recombination in Escherichia coli. Nat. Genet. 1998, 20:123-128.
40. Zhang Y., Muyrers J.P., Testa G., Stewart A.F. DNA cloning by homologous recombination in Escherichia coli. Nat. Biotechnol. 2000, 18:1314-1317.